Capvizr
THE DEAL, AT A GLANCE

Beyang Therapeutics

From the announcement
01Who is involvedBacked by Amplify Partners, included Databricks Ventures, Wing Venture Capital, othersFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02What happenedBeyang Therapeutics raised $30M Series A, announced 2026-08-12From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03Why it mattersBeyang Therapeutics' $30M Series A is a mid-to-lower percentile Healthcare & Life Sciences financing that sits inside an active trailing 30-day sector funding window…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Beyang Therapeutics · Financing Record

Explore source-linked visual explanations for Beyang Therapeutics. Unsupported claims are withheld while source review continues.

Record 10093 · Recorded date: 2026-08-12

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime